A Study of Inhaled Atropine Sulfate in Healthy Adults
Completed
U.S. Army Space and Missile Defense Command
Phase 1
2009-08-01
MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This
pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by
the ADPI to atropine delivery from the AtroPen autoinjector.
A Study of Inhaled Atropine Sulfate in Healthy Adults
Completed
University of Pittsburgh
Phase 1
2009-08-01
MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This
pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by
the ADPI to atropine delivery from the AtroPen autoinjector.
A Study of Inhaled Atropine Sulfate in Healthy Adults
Completed
MicroDose Defense Products L.L.C.
Phase 1
2009-08-01
MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This
pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by
the ADPI to atropine delivery from the AtroPen autoinjector.
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation
Completed
Craig J. Huang
N/A
2010-06-01
The purpose of this study is to determine if the antisialagogues (anti-salivary agents),
Atropine and Glycopyrrolate, are effective in reducing hypersalivation when sedating patients
with Ketamine for procedural sedation in the emergency department or abscess clinic. The
investigators will measure salivary flow rate by collecting oral secretions by oral
suctioning over a 30 minute time period starting with the administration of Ketamine. The
investigators hypothesize that patients who receive either atropine or glycopyrrolate will
have fewer oral secretions than patients who receive placebo.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
